PET Scanners Market Size (2025 – 2030)

The Global PET Scanners Market was valued at USD 1.9 billion in 2024 and is projected to grow at a CAGR of 6.2% from 2025 to 2030. The market is expected to reach USD 2.73 billion by 2030.

Positron Emission Tomography (PET) scanners are advanced imaging devices used in the diagnosis and monitoring of diseases such as cancer, cardiovascular diseases, and neurological disorders. PET scanners provide detailed, real-time images of metabolic activity in the body, enabling early disease detection and personalized treatment plans. The market's growth is driven by rising incidences of chronic diseases, technological advancements, and increasing demand for hybrid imaging systems like PET/CT and PET/MRI.

Key Market Insights

• Hybrid PET imaging systems, such as PET/CT, account for over 70% of the market share, driven by their ability to combine functional and anatomical imaging for enhanced diagnostic accuracy.

• Asia-Pacific is the fastest-growing region, with a CAGR of 8%, supported by expanding healthcare infrastructure, increasing medical tourism, and rising awareness of advanced diagnostic tools.

• PET scanners integrated with AI and machine learning are gaining traction, providing improved image reconstruction, reduced scan times, and enhanced diagnostic capabilities.

• Government initiatives and funding programs for cancer research and diagnostic imaging are driving market growth globally.

• The cost of PET scans and limited availability in rural areas remain challenges, with over 30% of the global population having limited access to advanced imaging technologies.

• The rising adoption of PET for cardiac imaging and neurodegenerative disorders such as Alzheimer’s disease presents significant growth opportunities in the market.

Global PET Scanners Market Drivers

Increasing Prevalence of Chronic Diseases is Driving Market Growth:

The growing global burden of chronic diseases, particularly cancer, cardiovascular conditions, and neurological disorders, is a primary driver of the PET scanners market. Cancer alone accounted for over 10 million deaths in 2024, with PET imaging emerging as a vital diagnostic and monitoring tool. PET scanners provide detailed metabolic imaging, enabling early disease detection, staging, and evaluation of treatment response. The increasing demand for non-invasive diagnostic methods and the integration of PET imaging into routine clinical practice further fuel market growth. Additionally, the aging population, which is more susceptible to chronic diseases, is contributing to the increased adoption of PET scanners.

Advancements in PET Technology is driving market growth:

Technological advancements in PET scanners, including the development of digital PET systems and hybrid imaging technologies such as PET/CT and PET/MRI, are significantly boosting market growth. Digital PET systems offer higher sensitivity, better image quality, and faster scan times compared to analog systems. Hybrid imaging combines functional and anatomical data, providing comprehensive diagnostic insights in a single scan. The incorporation of artificial intelligence (AI) and machine learning algorithms into PET systems enhances image analysis, reduces noise, and improves diagnostic accuracy. These innovations are driving adoption across hospitals, diagnostic centers, and research institutions.

Government Funding and Research Initiatives is driving market growth:

Government initiatives and funding programs aimed at advancing diagnostic imaging technologies and improving access to healthcare are positively impacting the PET scanners market. For example, national cancer research programs in the U.S., Europe, and Asia have allocated substantial budgets for improving cancer diagnostics and treatment. Additionally, governments are investing in expanding healthcare infrastructure, particularly in emerging economies, to make advanced diagnostic tools like PET scanners more accessible. These efforts are not only increasing the availability of PET scanners but also fostering innovations that enhance their clinical utility.

Global PET Scanners Market Challenges and Restraints

High Cost of PET Scanners and Procedures is restricting market growth: \

The high cost of PET scanners, ranging from USD 2 million to USD 5 million per unit, poses a significant barrier to market growth, particularly in low- and middle-income countries. Additionally, the cost of a single PET scan, which can range from USD 1,000 to USD 3,000, limits affordability for patients without adequate insurance coverage. Maintenance and operational costs further add to the financial burden on healthcare providers. These factors restrict the adoption of PET scanners in resource-constrained settings and create disparities in access to advanced diagnostic imaging.

Limited Availability and Accessibility is restricting market growth:

Despite their critical role in diagnosing and managing diseases, PET scanners are not widely available in rural and remote areas due to the high cost of installation and the need for specialized infrastructure. The requirement for radiotracers, which have a short half-life and need to be produced in proximity to imaging centers, further limits the accessibility of PET imaging. In many regions, the lack of trained personnel to operate and interpret PET scans adds to the challenges. Addressing these limitations is crucial for ensuring equitable access to PET imaging worldwide.

Market Opportunities

The PET scanners market presents significant growth opportunities, particularly in the adoption of hybrid imaging systems and the expansion of applications beyond oncology. The use of PET imaging in neurology, for conditions like Alzheimer’s disease and Parkinson’s disease, is gaining traction as early diagnosis becomes a focus in managing these disorders. Advances in radiotracer development are also opening new avenues for PET applications in cardiology and immunology. Furthermore, the integration of AI and data analytics into PET systems is enhancing diagnostic accuracy and workflow efficiency, making these technologies more appealing to healthcare providers. Emerging markets in Asia-Pacific, Latin America, and Africa offer untapped potential, driven by improving healthcare infrastructure and government support for advanced medical technologies.

PET SCANNERS MARKET REPORT COVERAGE:

PET Scanners Market Segmentation

PET Scanners Market Segmentation By Product:

• Full-Ring PET Scanners

• Partial-Ring PET Scanners

• Digital PET Scanners

Digital PET scanners dominate the market due to their superior sensitivity, faster scan times, and improved image quality. These features make them ideal for both clinical and research applications, accounting for over 50% of the market share in 2024.

PET Scanners Market Segmentation By Application:

• Oncology

• Neurology

• Cardiology

• Research Applications

The oncology segment is the largest application area for PET scanners, representing over 60% of market revenue in 2024. The rising prevalence of cancer and the critical role of PET imaging in early detection and treatment monitoring drive this dominance.

PET Scanners Market Regional Segmentation

• North America

• Asia-Pacific

• Europe

• South America

• Middle East and Africa

North America is the leading region in the PET scanners market, contributing over 45% of the total revenue in 2024. This dominance is attributed to a high prevalence of chronic diseases, advanced healthcare infrastructure, and significant investments in medical imaging technologies. The U.S. leads the region due to its robust research and development ecosystem, strong reimbursement policies, and early adoption of innovative imaging systems.

COVID-19 Impact Analysis on the PET Scanners Market

The COVID-19 pandemic had a mixed impact on the PET scanners market. In the early stages, the market faced a decline due to postponed elective procedures, supply chain disruptions, and reduced hospital revenues. These challenges slowed the adoption and deployment of PET scanners during the height of the crisis. However, the pandemic also underscored the critical role of advanced diagnostic tools in healthcare. As a result, there was a noticeable increase in investments aimed at improving healthcare infrastructure, with a particular focus on enhancing diagnostic capabilities. PET imaging, in particular, became invaluable for understanding the long-term effects of COVID-19, particularly on the lungs, brain, and heart, driving demand for these advanced technologies. In the post-pandemic landscape, the PET scanners market has rebounded strongly. Healthcare providers are increasingly prioritizing the expansion of advanced imaging technologies to improve diagnostic precision and patient outcomes. The renewed focus on early detection and accurate diagnosis of various health conditions, including COVID-19-related complications, has further accelerated the adoption of PET scanners. As healthcare systems adapt to the evolving needs of patient care, PET scanners are positioned to play a central role in diagnostic imaging, ensuring a sustained growth trajectory in the market.

Latest Trends/Developments

The PET scanners market is experiencing several transformative trends that are reshaping the landscape of diagnostic imaging. One significant advancement is the development of time-of-flight (TOF) technology, which improves image resolution and sensitivity, leading to more accurate and detailed scans. This technology is enhancing the precision of PET imaging, enabling earlier detection of diseases and better monitoring of treatment progress. Another groundbreaking development is the introduction of total-body PET scanners. These advanced devices can capture comprehensive data in a single scan, revolutionizing clinical research and patient care by significantly reducing scan times while providing more detailed information. This innovation is particularly valuable in oncology, neurology, and cardiology. AI-driven innovations are also making waves in the PET scanners market. Automated image analysis powered by artificial intelligence is streamlining the diagnostic process, reducing human error, and facilitating more personalized treatment planning. AI is helping clinicians interpret complex imaging data more effectively, resulting in improved patient outcomes. Hybrid imaging systems, such as PET/CT and PET/MRI, continue to gain popularity due to their ability to provide comprehensive diagnostic insights. By combining the strengths of different imaging modalities, these systems offer a more complete view of the body, enhancing diagnostic accuracy and improving treatment planning. Additionally, the development of new radiotracers is expanding the scope of PET imaging, particularly in fields like neurology and immunotherapy. These novel tracers allow for more precise targeting of specific diseases, enabling better disease detection and monitoring, especially in brain disorders and cancer treatments. As these trends continue to evolve, PET scanners are poised to play an even more pivotal role in modern healthcare.

Key Players

1. Siemens Healthineers

2. GE Healthcare

3. Philips Healthcare

4. Canon Medical Systems Corporation

5. Hitachi, Ltd.

6. United Imaging Healthcare

7. Mediso Ltd.

8. Positron Corporation

9. Spectrum Dynamics Medical

10. Cubresa Inc.